Ixabepilone in Treating Patients With Advanced Urinary Tract Cancer

This study has been completed.

Study NCT00021099 Information provided by National Cancer Institute (NCI)

First Received: July 11, 2001 Last Updated: July 23, 2008 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given

Publications:

Dreicer R, Li S, Manola J, Haas NB, Roth BJ, Wilding G. Phase 2 trial of epothilone B analog BMS-247550 (ixabepilone) in advanced carcinoma of the urothelium (E3800) : a trial of the eastern cooperative oncology group. Cancer. 2007 Jun 26; [Epub ahead of print]

Dreicer R, Li S, Manola J, et al.: Phase II trial of epothilone B analogue BMS-247550 in advanced carcinoma of the urothelium (E3800): a trial of the Eastern Cooperative Oncology Group. [Abstract] J Clin Oncol 24 (Suppl 18): A-4543, 2006.